A new cancer treatment based on genetic biomarkers rather than the specific type of cancer has won accelerated approval from the FDA.
Fda Approves Cancer Drug Targeting Genetics, Not Organs
USA TODAY, USA Today: Nation
Wed, 11/28/2018 - 6:55am
BING NEWS:
- FDA Approves Drug for Aggressive Small-Cell Lung Cancer
The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same ...
12/9/2024 - 8:09 am | View Link - Targeting novel molecular mechanisms may repair damaged DNA in cancer cells
Northwestern Medicine investigators have discovered new molecular mechanisms underlying DNA repair dysregulation in prostate cancer cells, findings that may inform the development of new targeted ...
12/9/2024 - 5:11 am | View Link - FDA Approves New Drug for Lung and Pancreatic Cancers
The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC) or pancreatic cancer.
12/5/2024 - 9:07 am | View Link - FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers
The approval stipulates use in advanced, unresectable, or metastatic disease that progressed on prior systemic therapy. Zenocutuzumab is the first approved therapy for NSCLC or pancreatic ...
12/4/2024 - 9:32 am | View Link - New understanding of a cancer-relevant protein reveals opportunities for drug discovery
A new approach to targeting a protein involved in cell division, which can misfunction in cancer, has revealed new insights into how it functions.
12/2/2024 - 3:44 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more